The clearances for the conduct of the country’s eight month-long Ivermectin clinical trial are expected to be released within this month, the Department of Science and Technology (DOST) said Friday, Jan. 7. Ivermectin pills (Photo courtesy of IndiaMart via PNA) “All clearances are anticipated...
The Department of Science and Technology (DOST) said Friday, Nov. 26, that initial results of the clinical study on tawa-tawa (Euphorbia hirta) as adjunctive treatment for coronavirus disease showed that tawa-tawa capsules are safe for patients who are experiencing mild COVID-19 symptoms. Tawa-tawa...
Results of the virgin coconut oil (VCO) trial at Philippine General Hospital (PGH) showed that hospitalized coronavirus disease (COVID-19) patients did not significantly benefit from VCO as an adjunct therapy. (MANILA BULLETIN FILE) The results of the VCO clinical trial at the PGH were presented by...
A total of 139 participants have so far been enrolled in the clinical trial on the use of sleep-aid supplement melatonin as adjuvant treatment for coronavirus disease (COVID-19) in patients with pneumonia, the Department of Science and Technology (DOST) said. (Photo by James Yarema on Unsplash) The...
The country’s clinical trials on the use of virgin coconut oil (VCO), lagundi (Chinese chaste tree) and tawa-tawa (Euphorbia hirta) as adjunct therapy, herbal medicine, and adjunctive treatment against coronavirus disease (COVID-19) may benefit the country’s farmers, the Department of Science...
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year....
The Department of Science and Technology (DOST) on Monday, Sept. 6, said it will release this month the results of its study on virgin coconut oil (VCO) and lagundi as potential treatments for patients with coronavirus disease (COVID-19). Department of Science and Technology Dr. Jaime Montoya,...
The Department of Science and Technology (DOST) is seeking more participants for its ongoing randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases. Tawa-tawa (Manila...
The Department of Science and Technology’s (DOST) Vaccine Expert Panel (VEP) has recommended the approval of the Sinovac’s clinical trial on the use of its coronavirus disease (COVID-19) vaccine for children. (NOEL CELIS / AFP / MANILA BULLETIN) VEP head Dr. Nina Gloriani said the panel nodded...
The antiviral drug, “Molnupiravir" as treatment for mild and moderate coronavirus disease (COVID-19) cases is now on Phase 3 clinical trial at the Lung Center of the Philippines. (Facebook/MANILA BULLETIN FILE PHOTO) The clinical trial started on May 17 this year and has enrolled a total of 11...
A total of 68 coronavirus disease (COVID-19) patients have already been recruited to participate in a randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus treatment for mild to moderate cases. Tawa-tawa (Manila Bulletin...
The Department of Science and Technology (DOST) reported Saturday, June 5, that 64 patients have been enrolled in the clinical trial aimed at looking into the effectiveness of virgin coconut oil (VCO) as an adjunct therapy for hospitalized coronavirus disease (COVID-19) patients. (Manila Bulletin...
